TY - JOUR
T1 - Vagal reflexes following an exercise stress test
T2 - A simple clinical tool for gene-specific risk stratification in the long QT syndrome
AU - Crotti, Lia
AU - Spazzolini, Carla
AU - Porretta, Alessandra P.
AU - Dagradi, Federica
AU - Taravelli, Erika
AU - Petracci, Barbara
AU - Vicentini, Alessandro
AU - Pedrazzini, Matteo
AU - La Rovere, Maria Teresa
AU - Vanoli, Emilio
AU - Goosen, Althea
AU - Heradien, Marshall
AU - George, Alfred L.
AU - Brink, Paul A.
AU - Schwartz, Peter J.
N1 - Funding Information:
This research was funded in part by National Institutes of Health grant HL68880 (Drs. George, Schwartz, and Crotti); Telethon Italia grant GGP07016 (Drs. Schwartz and Crotti); Italian Ministry of Foreign Affairs grant 2010 (Drs. Schwartz and Crotti); Ricerca Corrente “Identificazione di ‘geni modificatori’ modulanti il rischio di morte improvvisa in malattie cardiache aritmogene ereditarie” (Drs. Crotti and Schwartz). Dr. Spazzolini's research activity is partially supported by an educational grant of the Fondazione IRCCS Policlinico S. Matteo , Pavia, Italy. Dr. George reports that he has a research collaboration relationship with Gilead Sciences, and Allergan, Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2012/12/18
Y1 - 2012/12/18
N2 - Objectives: The study assessed whether heart rate (HR) reduction following an exercise stress test (ExStrT), an easily quantifiable marker of vagal reflexes, might identify high- and low-risk long QT syndrome (LQTS) type 1 (LQT1) patients. Background: Identification of LQTS patients more likely to be symptomatic remains elusive. We have previously shown that depressed baroreflex sensitivity, an established marker of reduced vagal reflexes, predicts low probability of symptoms among LQT1. Methods: We studied 169 LQTS genotype-positive patients < 50 years of age who performed an ExStrT with the same protocol, on and off β-blockers including 47 South African LQT1 patients all harboring the KCNQ1-A341V mutation and 122 Italian LQTS patients with impaired (IKs-, 66 LQT1) or normal (IKs+, 50 LQT2 and 6 LQT3) IKs current. Results: Despite similar maximal HR and workload, by the first minute after cessation of exercise the symptomatic patients in both IKs- groups had a greater HR reduction compared with the asymptomatic (19 ± 7 beats/min vs. 13 ± 5 beats/min and 27 ± 10 beats/min vs. 20 ± 8 beats/min, both p = 0.009). By contrast, there was no difference between the IKs+ symptomatic and asymptomatic patients (23 ± 9 beats/min vs. 26 ± 9 beats/min, p = 0.47). LQT1 patients in the upper tertile for HR reduction had a higher risk of being symptomatic (odds ratio: 3.28, 95% confidence interval: 1.3 to 8.3, p = 0.012). Conclusions: HR reduction following exercise identifies LQT1 patients at high or low arrhythmic risk, independently of β-blocker therapy, and contributes to risk stratification. Intense exercise training, which potentiates vagal reflexes, should probably be avoided by LQT1 patients.
AB - Objectives: The study assessed whether heart rate (HR) reduction following an exercise stress test (ExStrT), an easily quantifiable marker of vagal reflexes, might identify high- and low-risk long QT syndrome (LQTS) type 1 (LQT1) patients. Background: Identification of LQTS patients more likely to be symptomatic remains elusive. We have previously shown that depressed baroreflex sensitivity, an established marker of reduced vagal reflexes, predicts low probability of symptoms among LQT1. Methods: We studied 169 LQTS genotype-positive patients < 50 years of age who performed an ExStrT with the same protocol, on and off β-blockers including 47 South African LQT1 patients all harboring the KCNQ1-A341V mutation and 122 Italian LQTS patients with impaired (IKs-, 66 LQT1) or normal (IKs+, 50 LQT2 and 6 LQT3) IKs current. Results: Despite similar maximal HR and workload, by the first minute after cessation of exercise the symptomatic patients in both IKs- groups had a greater HR reduction compared with the asymptomatic (19 ± 7 beats/min vs. 13 ± 5 beats/min and 27 ± 10 beats/min vs. 20 ± 8 beats/min, both p = 0.009). By contrast, there was no difference between the IKs+ symptomatic and asymptomatic patients (23 ± 9 beats/min vs. 26 ± 9 beats/min, p = 0.47). LQT1 patients in the upper tertile for HR reduction had a higher risk of being symptomatic (odds ratio: 3.28, 95% confidence interval: 1.3 to 8.3, p = 0.012). Conclusions: HR reduction following exercise identifies LQT1 patients at high or low arrhythmic risk, independently of β-blocker therapy, and contributes to risk stratification. Intense exercise training, which potentiates vagal reflexes, should probably be avoided by LQT1 patients.
KW - autonomic nervous system
KW - exercise testing
KW - genetics
KW - long QT syndrome
KW - sudden death
UR - http://www.scopus.com/inward/record.url?scp=84871281671&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871281671&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2012.08.1009
DO - 10.1016/j.jacc.2012.08.1009
M3 - Article
C2 - 23158531
AN - SCOPUS:84871281671
SN - 0735-1097
VL - 60
SP - 2515
EP - 2524
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 24
ER -